表紙
市場調查報告書
商品編碼
909506

全EXOME定序 (WES)的全球市場

Whole Exome Sequencing

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球全EXOME定序 (WES) 市場相關調查分析,提供市場概要,主要企業,市場趨勢·促進因素,全球市場預測,各地區市場分析,競爭情形相關的系統性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球競爭企業的市場佔有率
  • 主要企業
  • 市場趨勢·促進因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他的歐洲
    • 亞太地區
    • 其他全球地區

第4章 競爭

  • AGILENT TECHNOLOGIES
  • AMBRY GENETICS CORPORATION
  • BGI EUROPE
  • EUROFINS GENOMICS GMBH
  • GENEWIZ
  • ILLUMINA
  • MACROGEN
  • ROCHE NIMBLEGEN
  • THERMO FISHER SCIENTIFIC

第5章 相關調查

目錄
Product Code: MCP15631

Abstract:

Global Whole Exome Sequencing Market to Reach $3.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Whole Exome Sequencing estimated at US$1 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at a CAGR of 18.7% over the analysis period 2020-2027. Systems, one of the segments analyzed in the report, is projected to record a 17.5% CAGR and reach US$944.2 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Kits segment is readjusted to a revised 21.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $310.8 Million, While China is Forecast to Grow at 18.5% CAGR

The Whole Exome Sequencing market in the U.S. is estimated at US$310.8 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$613.5 Million by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 16.6% and 16% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Services Segment to Record 17.8% CAGR

In the global Services segment, USA, Canada, Japan, China and Europe will drive the 17.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$356.7 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$405.7 Million by the year 2027.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies, Inc.
  • Ambry Genetics
  • BGI Europe
  • Eurofins Genomics GmbH
  • GENEWIZ, Inc.
  • Illumina, Inc.
  • Macrogen, Inc.
  • Roche Nimblegen, Inc.
  • Sengenics
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Whole Exome Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Drug Discovery and Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Drug Discovery and Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Personalized Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Personalized Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 15: World Current & Future Analysis for Agriculture & Animal Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 16: World 7-Year Perspective for Agriculture & Animal Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 17: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 18: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 19: USA Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 20: USA 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 21: USA Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 22: USA 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • CANADA
    • TABLE 23: Canada Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 24: Canada 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 25: Canada Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Canada 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • JAPAN
    • TABLE 27: Japan Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 28: Japan 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 29: Japan Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 30: Japan 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • CHINA
    • TABLE 31: China Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: China 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 33: China Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 34: China 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • EUROPE
    • TABLE 35: Europe Current & Future Analysis for Whole Exome Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 36: Europe 7-Year Perspective for Whole Exome Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 37: Europe Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Europe 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 39: Europe Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 40: Europe 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • FRANCE
    • TABLE 41: France Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 42: France 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 43: France Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: France 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • GERMANY
    • TABLE 45: Germany Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Germany 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 47: Germany Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Germany 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • ITALY
    • TABLE 49: Italy Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Italy 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 51: Italy Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 52: Italy 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 53: UK Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 54: UK 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 55: UK Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: UK 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 57: Rest of Europe Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Rest of Europe 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 59: Rest of Europe Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Rest of Europe 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 61: Asia-Pacific Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Asia-Pacific 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 63: Asia-Pacific Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Asia-Pacific 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 65: Rest of World Current & Future Analysis for Whole Exome Sequencing by Products & Services - Systems, Kits and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 66: Rest of World 7-Year Perspective for Whole Exome Sequencing by Products & Services - Percentage Breakdown of Value Sales for Systems, Kits and Services for the Years 2020 & 2027
    • TABLE 67: Rest of World Current & Future Analysis for Whole Exome Sequencing by Application - Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Rest of World 7-Year Perspective for Whole Exome Sequencing by Application - Percentage Breakdown of Value Sales for Diagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture & Animal Research and Other Applications for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42